Trials / Terminated
TerminatedNCT01954576
NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
A Phase II Study of the Optune System, Enhanced by Genomic Analysis to Identify the Genetic Signature of Response in the Treatment of Recurrent Glioblastoma Multiforme
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This pilot phase II trial studies how well Novocure's Tumor Treating Electric Fields (NovoTTF) therapy works in treating patients with recurrent glioblastoma multiforme. NovoTTF therapy uses a low intensity electric current to kill tumor cells. NovoTTF therapy may be effective treatment for brain cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovoTTF-100A | |
| PROCEDURE | Quality-of-life assessment | |
| GENETIC | Laboratory biomarker analysis |
Timeline
- Start date
- 2013-10-10
- Primary completion
- 2021-05-14
- Completion
- 2021-05-14
- First posted
- 2013-10-07
- Last updated
- 2022-10-31
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01954576. Inclusion in this directory is not an endorsement.